scholarly journals Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel

2008 ◽  
Vol 47 (2) ◽  
pp. 266-285 ◽  
Author(s):  
Martin S. Hirsch ◽  
Huldrych F. Günthard ◽  
Jonathan M. Schapiro ◽  
Françoise Brun‐Vézinet ◽  
Bonaventura Clotet ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Resistance Testing ◽  
International Aids ◽  
Antiretroviral Drug Resistance ◽  
Drug Resistance Testing ◽  
Antiretroviral Drug ◽  
Hiv 1

Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection

JAMA ◽  
2000 ◽  
Vol 283 (18) ◽  
pp. 2417 ◽  
Author(s):  
Martin S. Hirsch ◽  
Françoise Brun-Vézinet ◽  
Richard T. D'Aquila ◽  
Scott M. Hammer ◽  
Victoria A. Johnson ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Resistance Testing ◽  
Antiretroviral Drug Resistance ◽  
Drug Resistance Testing ◽  
Antiretroviral Drug ◽  
Hiv 1

scholarly journals Alternative Sample Types for HIV-1 Antiretroviral Drug Resistance Testing

2017 ◽  
Vol 216 (suppl_9) ◽  
pp. S834-S837 ◽  
Author(s):  
Dolly Singh ◽  
Adit Dhummakupt ◽  
Lilly Siems ◽  
Deborah Persaud
Keyword(s):  
Drug Resistance ◽  
Resistance Testing ◽  
Antiretroviral Drug Resistance ◽  
Drug Resistance Testing ◽  
Antiretroviral Drug ◽  
Hiv 1

Antiretroviral Drug Resistance Testing in Adults With HIV Infection

JAMA ◽  
1998 ◽  
Vol 279 (24) ◽  
pp. 1984 ◽  
Author(s):  
Martin S. Hirsch ◽  
Brian Conway ◽  
Richard T. D'Aquila ◽  
Victoria A. Johnson ◽  
Françoise Brun-Vézinet ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Hiv Infection ◽  
Resistance Testing ◽  
Antiretroviral Drug Resistance ◽  
Drug Resistance Testing ◽  
Antiretroviral Drug

An observational study of antiretroviral drug resistance in treatment-naïve patients with HIV infection in New Zealand, from 2007 to 2011

Sexual Health ◽  
2015 ◽  
Vol 12 (6) ◽  
pp. 556 ◽  
Author(s):  
Mark Hobbs ◽  
Jinyang Shi ◽  
Michael Maze ◽  
Simon Briggs
Keyword(s):  
Drug Resistance ◽  
New Zealand ◽  
Hiv Infection ◽  
Reverse Transcriptase ◽  
Resistance Testing ◽  
Reverse Transcriptase Inhibitors ◽  
Antiretroviral Drug Resistance ◽  
Drug Resistance Testing ◽  
Antiretroviral Drug ◽  
Treatment Naïve

Background Genotypic testing for antiretroviral drug resistance is recommended for all patients newly diagnosed with HIV infection. This study sought to quantify the prevalence of antiretroviral drug resistance in treatment-naïve patients with HIV infection in New Zealand. Methods: All genotypic antiretroviral drug resistance testing in New Zealand is performed at LabPLUS, Auckland City Hospital. The clinicians who requested antiretroviral drug resistance testing during the period 2007–2011 were contacted and were asked to identify which patients with HIV infection were treatment-naïve at the time of testing. Results of the antiretroviral drug resistance tests for treatment-naïve patients with HIV infection were reviewed and the prevalence of resistance determined. Results: Two hundred and 10 treatment-naïve patients with HIV infection who had antiretroviral drug resistance testing performed were included; 20 (10%) were found to have a significant resistance mutation. Nine patients had virus resistant to one or more nucleoside reverse transcriptase inhibitors, 13 to non-nucleoside reverse transcriptase inhibitors and one to protease inhibitors. Conclusions: The prevalence of antiretroviral drug resistance in treatment-naïve patients with HIV infection identified in this study is comparable to rates identified in studies from North America, the UK and Europe. This prevalence demonstrates the need for antiretroviral drug resistance testing for all treatment-naïve patients with HIV infection in New Zealand.

Sign in / Sign up

Export Citation Format

Share Document